Heather A. Newman, Ph.D. - Publications

Affiliations: 
2012 Biochemistry and Molecular Biology Johns Hopkins University, Baltimore, MD 

1/76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Newman HA, Romeo MJ, Lewis SE, Yan BC, Orlean P, Levin DE. Gpi19, the Saccharomyces cerevisiae homologue of mammalian PIG-P, is a subunit of the initial enzyme for glycosylphosphatidylinositol anchor biosynthesis. Eukaryotic Cell. 4: 1801-7. PMID 16278447 DOI: 10.1128/Ec.4.11.1801-1807.2005  0.351
Low-probability matches (unlikely to be authored by this person)
2017 Newman HA, Meluh PB, Lu J, Vidal J, Carson C, Lagesse E, Gray JJ, Boeke JD, Matunis MJ. A high throughput mutagenic analysis of yeast sumo structure and function. Plos Genetics. 13: e1006612. PMID 28166236 DOI: 10.1371/Journal.Pgen.1006612  0.266
1990 Esbenshade TA, Kamanna VS, Newman HA, Tortorella V, Witiak DT, Feller DR. In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Structure-activity relationships. Biochemical Pharmacology. 40: 1263-74. PMID 2403380 DOI: 10.1016/0006-2952(90)90392-X  0.196
1987 Feller DR, Kamanna VS, Newman HA, Romstedt KJ, Witiak DT, Bettoni G, Bryant SH, Conte-Camerino D, Loiodice F, Tortorella V. Dissociation of hypolipidemic and antiplatelet actions from adverse myotonic effects of clofibric acid related enantiomers. Journal of Medicinal Chemistry. 30: 1265-7. PMID 2441050  0.174
1981 Huzoor-Akbar, Patel S, Kokrady SS, Witiak DT, Newman HA, Feller DR. Effects of clofibrate and 6-substituted chroman analogs on human platelet function: mechanism of inhibitory action. Biochemical Pharmacology. 30: 2013-20. PMID 7271890 DOI: 10.1016/0006-2952(81)90213-6  0.151
1976 Witiak DT, Kuwano E, Feller DR, Baldwin JR, Newman HA, Sankrappa SK. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone. Journal of Medicinal Chemistry. 19: 1214-20. PMID 994152  0.145
1975 Witiak DT, Heilman WP, Sankarappa SK, Cavestri RC, Newman HA. Synthesis of ethyl 6-substituted-chroman- and -chromone-2-carboxylates. A comparative structure-activity study employing the 6-phenyl and phenoxy analogs in the triton hyperlipidemic rat model. Journal of Medicinal Chemistry. 18: 935-42. PMID 1159716  0.143
1989 Romstedt KJ, Kim SU, Witiak DT, Newman HA, Feller DR. Potent antiplatelet effects of cyclic clofibric acid (CPIB) analogs on human platelets. Thrombosis Research. 54: 289-99. PMID 2503906 DOI: 10.1016/0049-3848(89)90087-X  0.138
1986 Witiak DT, Kim SK, Romstedt K, Newman HA, Feller DR. Comparative antiaggregatory activity in human platelets of a benzopyranone aci-reductone, clofibric acid, and a 2,3-dihydrobenzofuran analogue. Journal of Medicinal Chemistry. 29: 2170-4. PMID 3097315  0.136
1989 Kamanna VS, Newman HA, Patel ST, Tehim AK, Witiak DT, Feller DR. Serum lipoprotein and apoprotein concentrations in 4-(4-chlorophenyl)-2-hydroxytetronic acid and clofibrate-treated cholesterol and cholic acid-fed rats. Lipids. 24: 25-32. PMID 2747427 DOI: 10.1007/BF02535260  0.134
1988 Witiak DT, Kim SK, Tehim AK, Sternitzke KD, McCreery RL, Kim SU, Feller DR, Romstedt KJ, Kamanna VS, Newman HA. Synthetic aci-reductones: 3,4-dihydroxy-2H-1-benzopyran-2-ones and their cis- and trans-4a,5,6,7,8,8a-hexahydro diastereomers. Antiaggregatory, antilipidemic, and redox properties compared to those of the 4-substituted 2-hydroxytetronic acids. Journal of Medicinal Chemistry. 31: 1437-45. PMID 3133477 DOI: 10.1021/Jm00402A032  0.126
1975 Witiak DT, Poochikian GK, Feller DR, Kenfield NA, Newman HA. 9-Chloro-2,3-dihydro-5H-1,4-dioxepino(6,5-b)benzofuran, a novel antilipidemic agent structurally related to clofibrate. Journal of Medicinal Chemistry. 18: 992-6. PMID 1159693  0.12
1981 Cavestri RC, Minatelli JA, Baldwin JR, Loh W, Feller DR, Newman HA, Sober CL, Witiak DT. Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models. Lipids. 16: 30-6. PMID 7219078 DOI: 10.1007/BF02534918  0.116
1982 Huzoor-Akbar, Witiak DT, Newman HA, Fertel RH, Feller DR. Potentiating effects of clofibrate on prostaglandin-dependent and -independent pathways of human platelet activation: evidence for involvement of cyclic AMP. Biochemical Pharmacology. 31: 2125-8. PMID 6288050 DOI: 10.1016/0006-2952(82)90434-8  0.112
1989 Phornchirasilp S, Patel ST, Hanson JM, Newman HA, Witiak DT, Feller DR. Pharmacologic effects of 4-chlorophenol in rats: comparison to clofibrate. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 191: 139-46. PMID 2726779 DOI: 10.3181/00379727-191-42899  0.11
1994 Hanna AN, Sharma HM, Kauffman EM, Newman HA. In vitro and in vivo inhibition of microsomal lipid peroxidation by MA-631. Pharmacology, Biochemistry, and Behavior. 48: 505-10. PMID 8090822  0.103
1978 Witiak DT, Cavestri RC, Newman HA, Baldwin JR, Sober CL, Feller DR. Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one. Journal of Medicinal Chemistry. 21: 1198-202. PMID 722728  0.098
1981 O'Brien M, Patel ST, Mukhopadhyay A, Newman HA, Feller DR, Kokrady SS, Witiak DT, Lanese RR, Rice JC. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals. Lipids. 16: 903-11. PMID 7329211 DOI: 10.1007/BF02534996  0.097
1976 Witiak DT, Newman HA, Poochikian GK, Loh W, Sankarappa SK. Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model. Lipids. 11: 384-91. PMID 1271976  0.089
1978 Witiak DT, Newman HA, Poochikian GK, Fogt SW, Baldwin JR, Sober CL, Feller DR. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate. Journal of Medicinal Chemistry. 21: 833-7. PMID 99517  0.089
1999 Powell SB, Newman HA, Pendergast JF, Lewis MH. A rodent model of spontaneous stereotypy: initial characterization of developmental, environmental, and neurobiological factors. Physiology & Behavior. 66: 355-63. PMID 10336165 DOI: 10.1016/S0031-9384(98)00303-5  0.087
1980 Saat YA, Newman HA, Hart RW, Allison DK. The effects of asbestos on plasma membrane; surface glycolipids and glycoproteins of Syrian hamster embryo cells. Journal of Environmental Pathology and Toxicology. 4: 435-41. PMID 7441126  0.086
1964 NEWMAN HA, ZILVERSMIT DB. ACCUMULATION OF LIPID AND NONLIPID CONSTITUENTS IN RABBIT ATHEROMA. Journal of Atherosclerosis Research. 4: 261-71. PMID 14181610  0.085
1983 Ottolenghi AC, Joseph LB, Newman HA, Stephens RE. Interaction of erythrocyte membranes with particulates. Environmental Health Perspectives. 51: 253-6. PMID 6315367  0.084
1993 Hanna AN, Feller DR, Witiak DT, Newman HA. Inhibition of low density lipoprotein oxidation by thyronines and probucol. Biochemical Pharmacology. 45: 753-62. PMID 8442772 DOI: 10.1016/0006-2952(93)90151-L  0.083
1982 Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. The Journal of Clinical Endocrinology and Metabolism. 54: 1210-5. PMID 7076797 DOI: 10.1210/jcem-54-6-1210  0.083
1995 Hanna AN, Titterington LC, Lantry LE, Stephens RE, Newman HA. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation. Biochemical Pharmacology. 50: 1627-33. PMID 7503765 DOI: 10.1016/0006-2952(95)02047-0  0.083
2000 Newman HA. The impact of ownership structure on the structure of compensation committees Journal of Business Finance and Accounting. 27: 653-678. DOI: 10.1111/1468-5957.00329  0.083
1980 Newman HA, Saat YA, Hart RW. Putative inhibitory effects of chrysotile, crocidolite, and amosite mineral fibers on the more complex surface membrane glycolipids and glycoproteins. Environmental Health Perspectives. 34: 103-11. PMID 7389680  0.083
1983 Mukhopadhyay A, Patel ST, O'Brien M, Kokrady SS, Newman HA, Witiak DT, Lanese RR, Rice JC, Feller DR. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: II. High sucrose-fed animals. Lipids. 18: 59-67. PMID 6835036 DOI: 10.1007/BF02534692  0.082
1971 Kelly LA, Newman HA. Pancreatic sterol ester hydrolase. Reversal of the reaction by bile salt. Biochimica Et Biophysica Acta. 231: 558-60. PMID 5282828 DOI: 10.1016/0005-2760(71)90127-5  0.081
1994 Hanna AN, Kauffman EM, Newman HA, Sharma HM. Prevention of oxidant stress by Student Rasayana (SR). Advances in Experimental Medicine and Biology. 366: 444-5. PMID 7771287  0.078
2012 Bannister JW, Newman HA, Yan Peng E. Influence of TARP regulations on executive compensation plans and corporate governance of exceptional assistance recipients International Journal of Disclosure and Governance. 9: 285-300. DOI: 10.1057/jdg.2011.20  0.076
1961 NEWMAN HA, McCANDLESS EL, ZILVERSMIT DB. The synthesis of C14-lipids in rabbit atheromatous lesions. The Journal of Biological Chemistry. 236: 1264-8. PMID 13728665  0.076
1984 Justement LB, Patel ST, Newman HA, Zwilling BS. Inhibition of macrophage-mediated tumor cell destruction by oxidized lipoproteins. Journal of the National Cancer Institute. 73: 469-74. PMID 6589438 DOI: 10.1093/Jnci/73.2.469  0.075
2000 Powell SB, Newman HA, McDonald TA, Bugenhagen P, Lewis MH. Development of spontaneous stereotyped behavior in deer mice: effects of early and late exposure to a more complex environment. Developmental Psychobiology. 37: 100-8. PMID 10954835 DOI: 10.1002/1098-2302(200009)37:2<100::Aid-Dev5>3.0.Co;2-6  0.074
1964 NEWMAN HA, RADIN NS. PERTINENT REFERENCES TO ANALYTICAL LIPID METHODS PUBLISHED RECENTLY. Journal of Lipid Research. 5: 632-4. PMID 14221112  0.071
1968 Newman HA, Gray GW, Zilversmit DB. Cholesterol ester formation in aortas of cholesterol-fed rabbits. Journal of Atherosclerosis Research. 8: 745-54. PMID 5688372  0.07
1966 Zilversmit DB, Newman HA. Does a metabolic barrier to circulating cholesterol protect the arterial wall? Circulation. 33: 7. PMID 5901762  0.066
1992 Sharma HM, Hanna AN, Kauffman EM, Newman HA. Inhibition of human low-density lipoprotein oxidation in vitro by Maharishi Ayur-Veda herbal mixtures. Pharmacology, Biochemistry, and Behavior. 43: 1175-82. PMID 1475302  0.066
1986 Israngkun PP, Newman HA, Patel ST, Duruibe VA, Abou-Issa H. Potential biochemical markers for infantile autism. Neurochemical Pathology. 5: 51-70. PMID 3561894  0.066
1979 Witiak DT, Loh W, Feller DR, Baldwin JR, Newman HA, Sober CL, Cavestri RC. Synthesis and pharmacological evaluation of cis-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-1-ones. Tricyclic analogues related to the antilipidemic drug clofibrate. Journal of Medicinal Chemistry. 22: 699-705. PMID 110933  0.065
2017 Gilman JL, Newman HA, Freeman R, Singh KE, Puckett RL, Morohashi DK, Stein C, Palomino K, Lebel RR, Kimonis VE. Two cases of Legg-Perthes and intellectual disability in Tricho-Rhino-Phalangeal syndrome type 1 associated with novel TRPS1 mutations. American Journal of Medical Genetics. Part A. PMID 28256045 DOI: 10.1002/ajmg.a.38204  0.064
1987 Negulesco JA, Noel SA, Newman HA, Naber EC, Bhat HB, Witiak DT. Effects of pure capsaicinoids (capsaicin and dihydrocapsaicin) on plasma lipid and lipoprotein concentrations of turkey poults. Atherosclerosis. 64: 85-90. PMID 3606725  0.063
1983 Stephens RE, Joseph LB, Daniel FB, Schenck KM, Newman HA, Lipetz PD, Millette JR. Interactions of chrysotile and benzopyrene in a human cell culture systems. Environmental Health Perspectives. 51: 257-65. PMID 6315368  0.06
1983 Joseph LB, Stephens RE, Ottolenghi AC, Lipetz PD, Newman HA. Morphological transformation in vitro of normal human fibroblasts by chrysotile. Environmental Health Perspectives. 51: 17-22. PMID 6315358  0.058
1973 Newman HA, Heilman WP, Witiak DT. Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model. Lipids. 8: 378-84. PMID 4724016  0.058
2019 Cao L, Boston A, Jegede O, Newman HA, Harrison SH, Newman RH, Ongeri EM. Inflammation and Kidney Injury in Diabetic African American Men. Journal of Diabetes Research. 2019: 5359635. PMID 30868076 DOI: 10.1155/2019/5359635  0.057
1971 Newman HA, Murad TM, Geer JC. Foam cells of rabbit atheromatous lesion. Identification and cholesterol uptake in isolated cells. Laboratory Investigation; a Journal of Technical Methods and Pathology. 25: 586-95. PMID 4331666  0.057
1962 NEWMAN HA, ZILVERSMIT DB. Quantitative aspects of cholesterol flux in rabbit atheromatous lesions. The Journal of Biological Chemistry. 237: 2078-84. PMID 14479335  0.056
1984 Patel ST, Newman HA, Yates AJ, Thibert P, Falko JM. Serum lipids and lipoprotein composition in spontaneously diabetic BB Wistar rats. Journal of Lipid Research. 25: 1072-83. PMID 6512413  0.056
1973 Bowman BU, Newman HA, Moritz JM, Koehler RM. Properties of mycobacteriophage DS6A. II. Lipid composition. The American Review of Respiratory Disease. 107: 42-9. PMID 4630313  0.055
1995 Sharma HM, Hanna AN, Kauffman EM, Newman HA. Effect of herbal mixture student Rasayana on lipoxygenase activity and lipid peroxidation. Free Radical Biology & Medicine. 18: 687-97. PMID 7750793  0.053
1981 Russell J, Newman HA, Sharma HM. Histochemical estrogen receptor assay. American Journal of Clinical Pathology. 75: 127-9. PMID 7457423  0.051
1986 Pritchard KA, Patel ST, Karpen CW, Newman HA, Panganamala RV. Triglyceride-lowering effect of dietary vitamin E in streptozocin-induced diabetic rats. Increased lipoprotein lipase activity in livers of diabetic rats fed high dietary vitamin E. Diabetes. 35: 278-81. PMID 3512338  0.05
2011 Bannister JW, Newman HA, Weintrop J. Tests for relative performance evaluation based on assumptions derived from proxy statement disclosures Review of Quantitative Finance and Accounting. 37: 127-148. DOI: 10.1007/S11156-010-0198-8  0.045
1997 Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. The Journal of Clinical Endocrinology and Metabolism. 82: 3421-4. PMID 9329379 DOI: 10.1210/jcem.82.10.4315  0.042
1965 Kelly LA, Newman HA. Blood coagulation, in normal and hypercholesterolemic dogs, unmodified by chylomicrons. Thrombosis Et Diathesis Haemorrhagica. 14: 466-72. PMID 5865606  0.04
1982 Friedman CI, Falko JM, Patel ST, Kim MH, Newman HA, Barrows H. Serum lipoprotein responses during active and stable weight reduction in reproductive obese females. The Journal of Clinical Endocrinology and Metabolism. 55: 258-62. PMID 7085852 DOI: 10.1210/jcem-55-2-258  0.039
1968 Newman HA, Gordesky SE, Hoppel C, Cooper C. The action of digitonin on rat liver mitochondria. Phospholipid content. The Biochemical Journal. 107: 381-5. PMID 4297045  0.038
2003 Balsam S, Mozes HA, Newman HA. Managing pro forma stock option expense under SFAS No. 123 Accounting Horizons. 17: 31-45. DOI: 10.2308/Acch.2003.17.1.31  0.038
2001 Turner CA, Presti MF, Newman HA, Bugenhagen P, Crnic L, Lewis MH. Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice. Behavior Genetics. 31: 393-400. PMID 11720125 DOI: 10.1023/A:1012226603255  0.038
2003 Bannister JW, Newman HA. Analysis of corporate disclosures on relative performance evaluation Accounting Horizons. 17: 235-246. DOI: 10.2308/acch.2003.17.3.235  0.034
2015 Linn-Pearl RN, Powell RM, Newman HA, Gould DJ. Validity of aqueocentesis as a component of anterior uveitis investigation in dogs and cats. Veterinary Ophthalmology. 18: 326-34. PMID 25557502 DOI: 10.1111/vop.12245  0.033
1999 Newman HA, Mozes HA. Does the composition of the compensation committee influence CEO compensation practices? Financial Management. 28: 41-53.  0.03
1966 Newman HA, Zilversmit DB. Uptake and release of cholesterol by rabbit atheromatous lesions. Circulation Research. 18: 293-302. PMID 5904319  0.029
1996 Bannister JW, Newman HA. Accrual usage to manage earnings toward financial analysts' forecasts Review of Quantitative Finance and Accounting. 7: 259-278.  0.025
1982 Patel DJ, Wong HY, Newman HA, Nightingale TE, Frasinel C, Johnson FB, Patel S, Coleman B. Effect of valium (diazepam) on experimental atherosclerosis in roosters. Artery. 10: 237-49. PMID 7181670  0.019
1966 Newman HA, Cordell AR, Prichard RW. Intracardiac myxomas. Literature review and report of six cases, one successfully treated. The American Surgeon. 32: 219-30. PMID 5326200  0.014
1975 Bowman BU, Fisher LJ, Witiak DT, Newman HA. Inactivation of phages DS6A and D29 by acetone extracts of Mycobacterium tuberculosis and Mycobacterium bovis. The American Review of Respiratory Disease. 112: 17-22. PMID 807139  0.013
1978 Newman HA, Leighton RF, Lanese RR, Freedland NA. Serum chromium and angiographically determined coronary artery disease. Clinical Chemistry. 24: 541-4. PMID 646861  0.011
2014 Bannister JW, Newman HA, Peng EY. Is excess compensation associated with the amount and content of compensation-Related risk disclosures in bank proxy statements? International Journal of Banking, Accounting and Finance. 5: 252-283. DOI: 10.1504/IJBAAF.2014.064322  0.01
1972 Heggen DW, Newman HA, Keller MD. A dual quality control system for large clinical laboratories. American Journal of Clinical Pathology. 58: 37-42. PMID 5034653  0.01
1972 Newman HA, Gordon EA, Heggen DW, Keller MD. Rapid extraction of triglycerides from human adipose tissue with petroleum ether. Clinical Chemistry. 18: 290-2. PMID 5020827  0.01
1965 NEWMAN HA, RADIN NS. NEW METHODS. Journal of Lipid Research. 6: 326-9. PMID 14328443  0.01
1957 CONN HO, DUNN JP, NEWMAN HA, BELKIN GA. Pulmonary emphysema simulating brain tumor. The American Journal of Medicine. 22: 524-33. PMID 13410947  0.01
Hide low-probability matches.